Photo: academy.eahad.org
May 1, 2026, 13:23
Key Advances Across the Full Spectrum of VWD at EAHAD 2025
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
”A century of progress in von Willebrand Disease continues to shape how we diagnose, understand, and treat patients today.
At EAHAD 2025, this session featured Carlo Castaman, Omid Seidizadeh, and Jeroen Eikenboom to explore key advances across the full spectrum of VWD.
Missed the live session? Relive the insights anytime on EAHAD Academy.”
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared this post on LinkedIn, adding:
”It was my pleasure to be invited to contribute to this EAHAD session on von Willebrand Disease.”
Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support